Regulatory Highlights-Reference-Cited by-同舟云学术

Regulatory Highlights

Published:2022-03-09 Issue:4 Volume:26 Page:1029-1037
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Teasdale Andrew¹,Borman Phil J.²^ORCID,Mullen Alexander K.³

Affiliation:

1. Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, United Kingdom

2. Director & Senior Fellow, Product Development & Supply, Medicinal Science & Technology, Pharma R&D, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom

3. AstraZeneca Global Sustainability and Product Environmental Sustainability, AstraZeneca, Macclesfield SK10 2NA, United Kingdom

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.2c00054

Reference44 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative Reversed-Phase Chromatography Platform Approach for the Fast and Accurate Characterization of Membrane Vesicles’ Protein Patterns;ACS Pharmacology & Translational Science;2024-04-11

2. A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical Industry;Journal of Pharmaceutical Sciences;2023-12

3. CMC Strategies and Advanced Technologies for Vaccine Development to Boost Acceleration and Pandemic Preparedness;Vaccines;2023-06-26

4. Development of the Methodology for in Silico Reactivity-Based Purge Predictions: Making Mirabilis Think Like a Chemist;Organic Process Research & Development;2023-03-29

5. Analytical Quality by Design Fundamentals and Compendial and Regulatory Perspectives;AAPS Introductions in the Pharmaceutical Sciences;2023